数位生物标记市场:各资料收集工具，各用途，各终端用户，各地区-规模，占有率，展望，机会分析，2023年～2030年

市场动态:

慢性病的患病率不断上升、数位医疗解决方案的采用不断增加、研究和开发的不断增加、以患者为中心的医疗保健应用程序的不断采用、智能手机的使用不断增加、新型可穿戴设备的出现以及治疗应用的扩大是预计推动医疗保健增长的主要因素。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球数位生物标记市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球数位生物标记市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球数位生物标记市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球数位生物标记市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场概况

• 报告概要
  • 市场定义和范围
• 摘要整理
• 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 数位医疗保健解决方案的采用增加
  • 高设备投资和资料保全的担忧
  • 健康相关行动应用程式的迅速的普及
• 影响分析
• 主要的焦点
• 法规情势
• 产品销售/核准
• PEST分析
• 波特分析
• 合併·收购情势

第4章 数位生物标记的全球市场-冠状病毒(COVID-19)流行的影响

• COVID-19流行病学
• 供给面和需求面的分析
• 经济影响

第5章 数位生物标记的全球市场:各资料收集工具，2023-2030年

• 穿戴式设备
• 置入式零组件/感测器
• 行动/平板电脑应用程式
• 平台
• 桌上型电脑(桌面)·软体
• 合併资料整合(资料的系统)

第6章 数位生物标记的全球市场:各用途，2023-2030年

• 与睡眠运动
• 心血管疾病
• 心情和行动
• 疼痛管理
• 神经退化性疾病
• 呼吸疾病

第7章 数位生物标记的全球市场:各终端用户，2023年～2030年

• 生物医药品企业
• 供应商
• 付款者

第8章 数位生物标记的全球市场:各地区，2023～2030年

• 北美
• 南美
• 欧洲
• 亚太地区
• 中东
• 非洲

第9章 竞争情形

• AliveCor Inc.
• Altoida Inc.
• Amgen Inc.
• Human API
• Fitbit, Inc.
• Biogen Inc.
• Bayer AG
• Akili Interactive Labs
• Evidation Health, Inc.
• GlaxoSmithKline Plc
• Eli Lilly and Company

第10章 章节

• 调查手法
• 关于出版社

Digital biomarkers are defined as objective, quantifiable physiological & behavioral data collected and measured through digital devices such as portables, wearables, implantables, and/or digestible. The data collected by these digital devices is typically used to explain, influence, or predict health-related outcomes. Thus, the demand for digital biomarkers is increasing with a rapid pace.

Market Dynamics:

Growing prevalence of chronic diseases, rising adoption of digital healthcare solutions, increasing research and development, growing adoption of patient-centric healthcare applications, rising use of smartphones, emergence of novel wearables, and expanding therapeutic applications are major factors expected to drive growth of the global digital biomarkers market.

For instance, in February 2023, Ad Scientiam announced the launch of two ambitious programs to develop and validate digital biomarkers for self-assessment of patients suffering from generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorders (NMOSD). The programs will leverage assets, methodologies, and expertise built by Ad Scientiam over the past five years and are supported by Alexion, AstraZeneca Rare Disease.

Key features of the study:

• This report provides in-depth analysis of the global digital biomarkers market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global digital biomarkers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AliveCor Inc., Altoida Inc., Amgen Inc., Human API, Fitbit, Inc., Biogen Inc, Bayer AG, Akili Interactive Labs, Evidation Health, Inc., GlaxoSmithKline Plc, and Eli Lilly and Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global digital biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarkers market.

Detailed Segmentation:

• Global Digital Biomarkers Market, By Data Collection Tools:
  • Wearable Devices
  • Implantable Components/Sensors
  • Mobile/Tablet Apps
  • Platforms
  • Desktop Based Software
  • Data Integration (Systems that Integrate Data)
• Global Digital Biomarkers Market, By Application:
  • Sleep and Movement
  • Cardiovascular Disease
  • Mood and Behavior
  • Pain Management
  • Neurodegenerative Disorders
  • Respiratory Conditions
• Global Digital Biomarkers Market, By End User:
  • Biopharmaceutical Companies
  • Providers
  • Payers
• Global Digital Biomarkers Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • AliveCor Inc.
  • Altoida Inc.
  • Amgen Inc.
  • Human API
  • Fitbit, Inc.
  • Biogen Inc.
  • Bayer AG
  • Akili Interactive Labs
  • Evidation Health, Inc.
  • GlaxoSmithKline Plc
  • Eli Lilly and Company

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Digital Biomarkers, By Data Collection Tools
  • Market Digital Biomarkers, By Application
  • Market Digital Biomarkers, By End User
  • Market Digital Biomarkers, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing adoption of digital healthcare solutions
  • High capital investment and data security concerns
  • Rapid adoption of health-related mobile applications
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Digital Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Digital Biomarkers Market, By Data Collection Tools, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Wearable Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Implantable Components/Sensors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Mobile/Tablet Apps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Desktop Based Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Data Integration (Systems that Integrate Data)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Digital Biomarkers Market, By Application, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Sleep and Movement
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Cardiovascular Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Mood and Behavior
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Neurodegenerative Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Respiratory Conditions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Digital Biomarkers Market, By End User, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Providers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Payers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Global Digital Biomarkers Market, By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)

9. Competitive Landscape

• AliveCor Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Altoida Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Human API
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fitbit, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biogen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Akili Interactive Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Evidation Health, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us